These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 7726975)
21. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"]. Gorshkov VA Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232 [No Abstract] [Full Text] [Related]
22. [The pharmacodynamics of the H+, K(+)-ATPase blocker omeprazole]. Kukes VG; Sokolova TV; Petrov IN Eksp Klin Farmakol; 1993; 56(6):21-2. PubMed ID: 8111288 [No Abstract] [Full Text] [Related]
23. [Gastrin-17 level in the omeprazole treatment of duodenal ulcer]. Belov DF; Maksimova ID; Ponomarev AA; Loginov AF Eksp Klin Gastroenterol; 2005; (6):28-32, 112. PubMed ID: 17378383 [TBL] [Abstract][Full Text] [Related]
24. Association between medically induced achlorhydria of the stomach and a severe postoperative infection? A report of two cases. Rantala A; Ovaska J Ann Chir Gynaecol; 1994; 83(3):268-70. PubMed ID: 7857075 [TBL] [Abstract][Full Text] [Related]
25. Should omeprazole be used for the treatment and prevention of duodenal ulcer as a monotherapeutic agent? Kadayifci A; Oksüzöğlu G Am J Gastroenterol; 1996 Jun; 91(6):1279-80. PubMed ID: 8651198 [No Abstract] [Full Text] [Related]
26. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. Park KN; Hahm JS; Kim HJ Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924 [TBL] [Abstract][Full Text] [Related]
27. [Effectiveness and safety of lansoprazole in the treatment of peptic ulcer]. Ramón Nogueira J; Esquivel Ayanegui F; Esquivel Rodríguez F; Sáenz V; Santoyo R Rev Gastroenterol Mex; 1996; 61(4):314-9. PubMed ID: 9072782 [TBL] [Abstract][Full Text] [Related]
28. [Efficacy of an ultrashort protocol in the eradication of Helicobacter pylori]. González Carro P; Legaz Huidobro ML; Pérez Roldán F; Ruíz Carrillo F; Pedraza Martín C; Sáez Bravo JM Rev Esp Enferm Dig; 1998 Aug; 90(8):594-5. PubMed ID: 9780793 [No Abstract] [Full Text] [Related]
29. Omeprazole and regulation of cytokine profile in Helicobacter pylori-infected patients with duodenal ulcer disease. Kountouras J; Boura P; Lygidakis NJ Hepatogastroenterology; 2000; 47(35):1301-4. PubMed ID: 11100337 [TBL] [Abstract][Full Text] [Related]
30. [Lansoprazole--profile of a new proton pump inhibitor]. Seifert E Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467 [TBL] [Abstract][Full Text] [Related]
31. [Prospective study of erradication of Helicobacter pylori in patients with duodenal ulcer: analysis of antral and gastric body biopsies]. Portell DP; Figueroa G; Toledo MS; Troncoso M; Acuña R Rev Med Chil; 1996 Jan; 124(1):21-5. PubMed ID: 8762615 [TBL] [Abstract][Full Text] [Related]
32. [One week triple therapy for eradication of Helicobacter pylori infection: simple and effective]. Diehl HG Leber Magen Darm; 1995 Dec; 25(6):283. PubMed ID: 8577220 [No Abstract] [Full Text] [Related]
33. [Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?]. Lanas Arbeloa A; Serrano Aulló MT Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():20-4. PubMed ID: 9549198 [No Abstract] [Full Text] [Related]
34. Omeprazole therapy and salivary flow rate in duodenal ulcer patients. Namiot Z; Stasiewicz J; Kralisz M; Kozuszyńska-Topór M; Markowski AR; Aljanaby FK; Kemona A; Górski J Med Sci Monit; 2001; 7(2):276-81. PubMed ID: 11257735 [TBL] [Abstract][Full Text] [Related]